Cargando…

A novel compound heterozygous variant in ALPK3 induced hypertrophic cardiomyopathy: a case report

BACKGROUND: Malignant hypertrophic cardiomyopathy (HCM) phenotypes have potential risks of severe heart failure, fatal arrhythmia, and sudden cardiac death. Therefore, it is critical to predict the clinical outcomes of these patients. It was reported recently that the alpha kinase 3 (ALPK3) gene was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Tiange, Jin, Yuxi, Liu, Rui, Hua, Yimin, Zhou, Kaiyu, Luo, Shuhua, Li, Yifei, Zhang, Donghui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311070/ https://www.ncbi.nlm.nih.gov/pubmed/37396576 http://dx.doi.org/10.3389/fcvm.2023.1212417

Ejemplares similares

The Involvement of ALPK3 in Hypertrophic Cardiomyopathy in East Asia
por: Dai, Jiaqi, et al.
Publicado: (2022)

Two New Cases of Hypertrophic Cardiomyopathy and Skeletal Muscle Features Associated with ALPK3 Homozygous and Compound Heterozygous Variants
por: Jorholt, John, et al.
Publicado: (2020)

Case Report: Whole Exome Sequencing Identifies Compound Heterozygous Variants in TSFM Gene Causing Juvenile Hypertrophic Cardiomyopathy
por: Yang, Jamie O., et al.
Publicado: (2022)

Genetic Clues on Implantable Cardioverter-Defibrillator Placement in Young-Age Hypertrophic Cardiomyopathy: A Case Report of Novel MYH7 Mutation and Literature Review
por: Li, Xing, et al.
Publicado: (2021)

Case report: Rare novel MIPEP compound heterozygous variants presenting with hypertrophic cardiomyopathy, severe lactic acidosis and hypotonia in a Chinese infant
por: Wang, Ling, et al.
Publicado: (2023)

The Molecular Role of Immune Cells in Dilated Cardiomyopathy
por: Wang, Enping, et al.
Publicado: (2023)

Basic science methods for the characterization of variants of uncertain significance in hypertrophic cardiomyopathy
por: Doh, Chang Yoon, et al.
Publicado: (2023)

Misdiagnosed myocarditis in arrhythmogenic cardiomyopathy induced by a homozygous variant of DSG2: a case report
por: Liu, Xuwei, et al.
Publicado: (2023)

Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy
por: Lopes, Luis R, et al.
Publicado: (2021)

Novel Compound Heterozygous PKLR Mutation Induced Pyruvate Kinase Deficiency With Persistent Pulmonary Hypertension in a Neonate: A Case Report
por: Lin, Sha, et al.
Publicado: (2022)

COVID-19 in Adults With Hypertrophic Cardiomyopathy
por: Arabadjian, Milla E., et al.
Publicado: (2021)

Genetic variants, pathophysiological pathways, and oral anticoagulation in patients with hypertrophic cardiomyopathy and atrial fibrillation
por: Wang, Shengnan, et al.
Publicado: (2023)

Clinical significance of genetic variation in hypertrophic cardiomyopathy: comparison of computational tools to prioritize missense variants
por: Barbosa, Pedro, et al.
Publicado: (2022)

Hypertrophic Cardiomyopathy: From Phenotype and Pathogenesis to Treatment
por: Cheng, Zeyi, et al.
Publicado: (2021)

Precision and genomic medicine for dilated and hypertrophic cardiomyopathy
por: Nomura, Seitaro, et al.
Publicado: (2023)

A cohort study to investigate the potential indicators for prenatal echocardiographic detection of suspected coarctation of the aorta
por: Guo, Nan, et al.
Publicado: (2023)

Novel Morphological Features on CMR for the Prediction of Pathogenic Sarcomere Gene Variants in Subjects Without Hypertrophic Cardiomyopathy
por: van der Velde, Nikki, et al.
Publicado: (2021)

Anxiety Predicts Poor Prognosis in Patients With Hypertrophic Cardiomyopathy
por: He, Chao-Jie, et al.
Publicado: (2022)

Transcriptional bursts and heterogeneity among cardiomyocytes in hypertrophic cardiomyopathy
por: Burkart, Valentin, et al.
Publicado: (2022)

Cardiovascular Imaging in Pregnancy: Valvulopathy, Hypertrophic Cardiomyopathy, and Aortopathy
por: Ismail, Haneen, et al.
Publicado: (2022)

Ventricular arrhythmia and sudden cardiac death in hypertrophic cardiomyopathy: From bench to bedside
por: Shen, Hua, et al.
Publicado: (2022)

Body composition and mortality in a cohort study of Chinese patients with hypertrophic cardiomyopathy
por: Zhou, Ke, et al.
Publicado: (2023)

Myosin-binding Protein C Compound Heterozygous Variant Effect on the Phenotypic Expression of Hypertrophic Cardiomyopathy
por: Rafael, Julianny Freitas, et al.
Publicado: (2017)

Non-pharmaceutical Interventions for Hypertrophic Cardiomyopathy: A Mini Review
por: He, Miaomiao, et al.
Publicado: (2021)

Stable Rates of Obstructive Hypertrophic Cardiomyopathy in a Contemporary Era
por: Butzner, Michael, et al.
Publicado: (2022)

Further Considerations in Childhood-Onset Hypertrophic Cardiomyopathy Genetic Testing
por: Monasky, Michelle M., et al.
Publicado: (2021)

Machine Learning for Predicting Heart Failure Progression in Hypertrophic Cardiomyopathy
por: Fahmy, Ahmed S., et al.
Publicado: (2021)

Electrocardiographic and Echocardiographic Predictors of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
por: Mandeş, Leonard, et al.
Publicado: (2022)

Significance and Determinants of Plasma Apelin in Patients With Obstructive Hypertrophic Cardiomyopathy
por: Yang, Chengzhi, et al.
Publicado: (2022)

Case report: Metastatic melanoma masquerading as apical hypertrophic cardiomyopathy
por: Ashraf, Muddasir, et al.
Publicado: (2022)

Advanced searching for hypertrophic cardiomyopathy heritability in real practice tomorrow
por: Chumakova, Olga S., et al.
Publicado: (2023)

Twenty-four hour variability of inverted T-waves in patients with apical hypertrophic cardiomyopathy
por: Ma, Fei, et al.
Publicado: (2022)

First-in-man application of Liwen RF™ ablation system in the treatment of drug-resistant hypertrophic obstructive cardiomyopathy
por: Wang, Zihao, et al.
Publicado: (2022)

Association of QTc Interval and V4-S Wave With Appropriate ICD Therapy in Hypertrophic Cardiomyopathy
por: Zhang, Nixiao, et al.
Publicado: (2022)

Prenatal Management Strategy for Immune-Associated Congenital Heart Block in Fetuses
por: Liao, Hongyu, et al.
Publicado: (2021)

Transfemoral Occlusion of Doubly Committed Subarterial Ventricular Septal Defect Using the Amplatzer Duct Occluder-II in Children
por: Tang, Changqing, et al.
Publicado: (2022)

The Impact of Ischemia Assessed by Magnetic Resonance on Functional, Arrhythmic, and Imaging Features of Hypertrophic Cardiomyopathy
por: Aguiar Rosa, Sílvia, et al.
Publicado: (2021)

Ventricular Arrhythmia in Septal and Apical Hypertrophic Cardiomyopathy: The French-Canadian Experience
por: Steinberg, Christian, et al.
Publicado: (2020)

Thoracoscopic Trans-mitral Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy in the Elderly
por: Wei, Peijian, et al.
Publicado: (2022)

Hypertrophic Obstructive Cardiomyopathy: Comparison of Outcomes After Myectomy or Alcohol Ablation
por: Meng, Xiangbin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vpudo4124gskvpf605d8qhisll